Incyte Corporation
USD117.96
+2.31 (+2.00%)
CEO
William J. Meury
IPO Date
1993-11-04
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$115.65
Prev. Close
$115.65
Day Low
$115.20
Day High
$118.94
52W Low
$67.20
52W High
$119.60
Market Cap
$23.57B
Volume
0.66M
| 4,950 |
| $115.09 |
| 16 Jul 2026 | Mayes Patrick A | EVP & Chief Scientific Officer | F-InKind | Disposed | 437 | $114.88 |
| 16 Jul 2026 | Mayes Patrick A | EVP & Chief Scientific Officer | F-InKind | Disposed | 1,512 | $115.09 |
| 16 Jul 2026 | Tray Thomas | Principal Accounting Officer | F-InKind | Disposed | 692 | $114.88 |
| 16 Jul 2026 | Tray Thomas | Principal Accounting Officer | F-InKind | Disposed | 1,098 | $115.09 |
| 16 Jul 2026 | Stein Steven H | CMO & Head of Late-Stage Dev. | F-InKind | Disposed | 21,830 | $114.88 |
| 16 Jul 2026 | Stein Steven H | CMO & Head of Late-Stage Dev. | S-Sale | Disposed | 28,237 | $113.05 |
| 16 Jul 2026 | Stein Steven H | CMO & Head of Late-Stage Dev. | F-InKind | Disposed | 3,088 | $115.09 |
| 16 Jul 2026 | Issa Mohamed Khairie | EVP, Head of U.S. Commercial | F-InKind | Disposed | 1,099 | $115.09 |
| Purchase |
| $1,001 - $15,000 |
| 5 Oct 2017 | Shelley Moore Capito | Shelley Moore Capito | Purchase | $1,001 - $15,000 |
| Disclosed | Representative | Office | Type | Amount |
|---|---|---|---|---|
| 2 Jun 2025 | Rob Bresnahan | Rob Bresnahan | Sale | $1,001 - $15,000 |
| 8 Oct 2024 | Ro Khanna | Ro Khanna | Sale | $1,001 - $15,000 |
| 5 Apr 2024 | Ro Khanna | Ro Khanna | Purchase | $1,001 - $15,000 |
| 8 Nov 2023 | Ro Khanna | Ro Khanna | Sale | $1,001 - $15,000 |
| 8 Nov 2023 | Ro Khanna | Ro Khanna | Sale | $1,001 - $15,000 |
| 6 Oct 2023 | Ro Khanna | Ro Khanna | Sale | $1,001 - $15,000 |
| 11 Jul 2023 | Ro Khanna | Ro Khanna | Purchase | $1,001 - $15,000 |
| 11 Jul 2023 | Ro Khanna | Ro Khanna | Purchase | $1,001 - $15,000 |
| 12 Jun 2023 | Ro Khanna | Ro Khanna | Purchase | $1,001 - $15,000 |
| 17 Apr 2023 | Daniel Goldman | Daniel Goldman | Sale | $1,001 - $15,000 |